Opto Circuits Group Company, Cardiac Science, Introduces Powerheart G5 AED to U.S., Canadian Markets

BENGALURU, May 13, 2015 /PRNewswire/ --

Powerheart G5 is First FDA-cleared AED to Combine Fully Auto Shock Delivery, Fast Shock Times, and Dual-language Functionality  

Opto Circuits (India) Ltd. (Bloomberg: OPTCIN; Reuters: OPTO.NS; NSE: OPTOCIRCUI; BSE: 532391) announced today that its group company, Cardiac Science, has unveiled its newest Automated External Defibrillator (AED) to the U.S. and Canadian marketplaces, representing a technological milestone in the AED industry and high anticipation from its loyal customers.

The Powerheart^® G5 is the first FDA-cleared AED to combine fully automatic shock delivery, dual-language functionality, variable escalating energy, and fast shock times to help save a Sudden Cardiac Arrest(SCA) victim's life. SCA is the No.1 global cause of death with 17.3 million deaths each year, according to the American Heart Association.

Learn more at  www.cardiacscience.com/powerheartg5

"The North American AED market has yearned for an AED of this technology, scope, and importance," said Vinod Ramnani, Chairman and Managing Director, Opto Circuits (India) Ltd. "We have seen the impact of this product when we launched it in Europe back in 2012: immediate market share, adoption, and demand."

Along with its sister AED, the Powerheart^® G3, the Powerheart G5 is designed to enable rescuers to swiftly provide effective, life-saving therapy to aid a person who has suffered SCA, a condition in which the heart suddenly stops beating due to irregularities in its electrical system.

"As more and more countries recognize the threat posed by SCA, legislation and public attitudes are steering buying decisions. This, in turn, has allowed our company to maintain price-points as customers want AEDs that are easy to use, ready for operation, and feature advanced technology," added Ramnani.

About Opto Circuits (India) Limited 

Opto Circuits (India) Ltd. (OCI) is a vertically integrated multinational medical technology group that specializes in primary, acute and critical care products for the global markets. Group companies such as Cardiac Science, Criticare, Eurocor, Mediaid, AMDL and Unetixs Vascular are leaders in vital signs monitors, emergency cardiac care equipment, vascular treatments and sensing technologies. Our USFDA listed and CE marked products are marketed in more than 150 countries and sold through direct and indirect sales channels across many emerging and developed economies. We've been ranked in Forbes' Asia's 200 Best under a Billion lists in 2008, 2009 and 2011.

For more information, please visit www.optoindia.com.

Media Contact:
Shahab Shaikh,
[email protected],
+91-9320897525,
Concept Public Relations India Limited